Medcura Overview

  • Founded
  • 2007

Founded
  • Status
  • Private

  • Employees
  • 19

Employees
  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $7.5M

  • Investors
  • 13

Medcura General Information

Description

Developer of wound care platform designed to be used across a broad spectrum of clinical and non-clinical setups for managing many high-impact surgical bleeds. The company's platform transforms highly abundant natural materials into advanced wound treatment and hemostatic products for surgical, military, and consumer applications, it develops Rapid-Seal, antibacterial barriers and a robust and diverse range of products that innovatively control bleeding, enabling doctors to improve bleeding management while creating antibacterial barriers and enhancing healing environments.

Contact Information

Formerly Known As
Remedium Technologies, gel-e
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Primary Office
  • 5650 Rivertech Court
  • Suite S
  • Riverdale, MD 20737
  • United States
+1 (240) 000-0000

Medcura Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medcura Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC (Series A1) 08-Sep-2022 $7.5M 000.00 000.00 Completed Generating Revenue
13. Secondary Transaction - Private 000.00 Completed Generating Revenue
12. Secondary Transaction - Private 01-Jun-2022 000.00 Completed Generating Revenue
11. Later Stage VC 01-Nov-2021 00.00 000.00 000.00 Completed Generating Revenue
10. Later Stage VC (Series A) 12-Aug-2021 00.00 0000 000.00 Completed Generating Revenue
9. Later Stage VC (Series A) 21-Sep-2020 00.000 00.000 0000 Completed Generating Revenue
8. Angel (individual) 31-Dec-2018 00.000 00.000 Completed Generating Revenue
7. Grant 01-Apr-2018 000 00.00 Completed Pre-Clinical Trials
6. Grant 19-Feb-2018 $1.4M $3.1M Completed Generating Revenue
5. Seed Round 13-Jul-2017 $3.1M $3.1M 00.00 Completed Generating Revenue
To view Medcura’s complete valuation and funding history, request access »

Medcura Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1 0,000,000 00.000000 00.0 00.0 00 00.0 000
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Seed 6,199,999 $0.001000 $0.5 $0.5 1x $0.5 18.85%
To view Medcura’s complete cap table history, request access »

Medcura Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of wound care platform designed to be used across a broad spectrum of clinical and non-clinical setups for man
Other Pharmaceuticals and Biotechnology
Riverdale, MD
19 As of 2023
000.00
00.00 0000-00-00
00000000000 000.00

000000

aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugia
0000000000000
Schlieren, Switzerland
00 As of 0000
000.00
000000000 000.00

000000

iqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut
0000000000000
Vancouver, Canada
00 As of 0000
000.00
000000 - 000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Medcura Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InSphero Formerly VC-backed Schlieren, Switzerland 00 000.00 000000000 000.00
000000 0000000000 Venture Capital-Backed Vancouver, Canada 00 000.00 000000 - 000 000.00
0000000 000000000 Venture Capital-Backed San Francisco, CA 00 000.00 00000000000 000.00
00000 00000000000 Venture Capital-Backed Middleton, WI 00 0000 0000000000 0 0000
00000 0000000000 0 Formerly PE-Backed White Plains, NY 000 000.00 000000&0 000.00
To view Medcura’s complete competitors history, request access »

Medcura Patents

Medcura Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220347341-A1 Hydrophobically-modified biopolymer materials Pending 03-Oct-2019 000000000
CA-3156813-A1 Hydrophobically-modified biopolymer materials Pending 03-Oct-2019 000000000
CA-3135980-A1 System and method to reduce tissue or organ adhesion Pending 05-Mar-2019 0000000000
EP-3934659-A1 System and method to reduce tissue or organ adhesion Pending 05-Mar-2019 0000000000
EP-3934659-A4 System and method to reduce tissue or organ adhesion Pending 05-Mar-2019 A61K31/722
To view Medcura’s complete patent history, request access »

Medcura Executive Team (9)

Name Title Board Seat Contact Info
James Buck Chief Executive Officer, President & Board Member
Larry Tiffany JD Co-Founder, Chief Operating Officer & Board Member
Matthew Dowling Ph.D Co-Founder, Chief Scientific Officer & Board Member
Colleen Nye Vice President, Product Development
Srinivasa Raghavan Ph.D Scientific Advisory Board Member
You’re viewing 5 of 9 executive team members. Get the full list »

Medcura Board Members (4)

Name Representing Role Since
James Buck Medcura Chief Executive Officer, President & Board Member 000 0000
Larry Tiffany JD Medcura Co-Founder, Chief Operating Officer & Board Member 000 0000
Matthew Dowling Ph.D Medcura Co-Founder, Chief Scientific Officer & Board Member 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Medcura Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medcura Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ironwood Investment Management Venture Capital Minority 000 0000 000000 0
Aubrey Capital Venture Capital Minority 000 0000 000000 0
Delaware Crossing Investor Group Angel Group 000 0000 000000 0
New York Angels Angel Group Minority 000 0000 000000 0
Sung Capital Partners Family Office Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »